BRIEF-Bioptix enters agreement with certain shareholders providing for termination of certain pending litigation
* On Jan 18, entered agreement with certain shareholders providing for termination of certain pending litigation - SEC filing
Jan 5 Emblem Corp
* Emblem Corp announces $10 million special warrant bought deal financing
* Emblem - entered into engagement letter pursuant to which underwriters have agreed to purchase 2.8 million special warrants of co at $3.63 per special warrant
* Company intends to use net proceeds of offering to fund planned expansion of its facility in Paris, Ontario Source text for Eikon: Further company coverage:
NEW YORK, Jan 20 A U.S. bankruptcy court judge granted Avaya Inc approval on Friday to tap $425 million of the $725 million loan proposed to carry the telecommunications company through its restructuring, funds the company said were essential to continue operations.
Jan 20 Merck & Co said it agreed to enter into a settlement and license agreement with Bristol-Myers Squibb Co and Ono Pharmaceutical Co Ltd to resolve all global patent-infringement litigation related to its cancer drug, Keytruda.